Table 1 Clinical characteristics of the patients with or without central fibrous area in the glomerular vascular pole at the time of kidney biopsy
Total (n = 101) | CFA (+) (n = 56) | CFA (−) (n = 45) | p value | |
|---|---|---|---|---|
Age (year), median (IQR) | 62.5 (55.3–71.0) | 67.0 (53.0–72.0) | 51.5 (35.3–67.3) | 0.0016 |
Gender (male/female, %) | 51/50 (50.5) | 29/27 (51.8) | 22/23 (48.9) | 0.77 |
Body mass index (kg/m2), median (IQR) | 22.9 (20.6–26.0) | 23.0 (20.5–26.1) | 22.8 (21.1–24.8) | 0.92 |
Hypertension, n (%) | 56 (56.0) | 38 (69.1) | 18 (40.0) | 0.0036 |
Diabetes mellitus, n (%) | 23 (22.3) | 15 (26.8) | 8 (17.8) | 0.28 |
Hyperlipidemia, n (%) | 46 (47.4) | 32 (58.2) | 14 (33.3) | 0.015 |
Hyperuricemia, n (%) | 21 (22.3) | 11 (20.8) | 10 (24.4) | 0.67 |
Proteinuria (g/g creatinine) | 0.90 | |||
< 0.3, n (%) | 13 (12.9) | 7 (12.5) | 6 (13.3) | |
0.3–1.0, n (%) | 29 (28.7) | 17 (30.4) | 12 (26.7) | |
1.0–3.0, n (%) | 19 (18.8) | 10 (17.9) | 9 (20.0) | |
> 3.0, n (%) | 40 (39.6) | 22 (39.3) | 18 (40.0) | |
Hematuria (RBC /hpf) | 0.34 | |||
< 5, n (%) | 34 (33.7) | 19 (33.9) | 15 (33.3) | |
5–20, n (%) | 23 (22.8) | 16 (28.6) | 7 (15.6) | |
20–100, n (%) | 9 (8.9) | 5 (8.9) | 4 (8.9) | |
> 100, n (%) | 35 (34.7) | 16 (28.6) | 19 (42.2) | |
Serum creatinine (mg/dL), median (IQR) | 0.86 (0.66–1.17) | 0.91 (0.67–1.19) | 0.84 (0.62–1.15) | 0.59 |
eGFR (ml/min/1.73m2), median (IQR) | 63.5 (39.0–83.7) | 58.2 (37.9–77.0) | 68.8 (43.9–92.0) | 0.15 |